1991
DOI: 10.1097/00000542-199109001-00214
|View full text |Cite
|
Sign up to set email alerts
|

Deep Venous Thrombosis Prophylaxis by Low Molecular Weight Heparinin Neurosurgical Patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
24
0
1

Year Published

1995
1995
2015
2015

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 29 publications
(25 citation statements)
references
References 0 publications
0
24
0
1
Order By: Relevance
“…One additional RCT was identified through manual searches of the reference lists of these 8 trials. 21 No additional RCTs were identified through a review of the Internet sources or conference proceedings ( Figure 1). …”
Section: Identification Of Eligible Studiesmentioning
confidence: 99%
See 2 more Smart Citations
“…One additional RCT was identified through manual searches of the reference lists of these 8 trials. 21 No additional RCTs were identified through a review of the Internet sources or conference proceedings ( Figure 1). …”
Section: Identification Of Eligible Studiesmentioning
confidence: 99%
“…Eight trials with 1441 patients (mean age, 52.4 years; 51.6% male) were initially identified. 13,[15][16][17][18][19][20][21] One additional unique trial by Bostrom et al 14 compared heparin and electric stimulation, and dextran was excluded. This trial from 1986 (Jadad score = 1; 104 patients) was disqualified from analysis because it did not isolate the effects of heparin for analysis purposes.…”
Section: Characteristics Of Eligible Studiesmentioning
confidence: 99%
See 1 more Smart Citation
“…For example, venography and I 125 fibrinogen were used to diagnose DVTs in 4 of the 6 trials, 2,11,13,34 tests that are not routinely used today, although they may be more sensitive than Doppler ultrasonography. Moreover, all patients underwent screening for DVT regardless of symptoms.…”
mentioning
confidence: 99%
“…При хирургическом лечении онкологических заболеваний частота развития ВТ составляет 6,25-55,5% (в среднем 15,9%) на фоне применения анти коагулянтов и компрессионной терапии [26][27][28][29][30][31][32][33][34][35][36]. У больных нейрохирургического профиля на фоне применения механических, фармакологических средств профилактики и их комбинации частота ин струментальной верификации послеоперационных ВТ колеблется от 1,5 до 26,3% и в среднем составля ет 12,5% [37][38][39][40][41][42][43][44][45][46][47]. У пациентов отделения интенсив ной терапии на фоне соблюдения превентивных протоколов вероятность развития тромбоза коле блется от 5,5 до 33% (в среднем 12,0%) [48][49][50][51][52][53][54][55][56][57].…”
Section: флебология 1 2015unclassified